Targeting MondoA: A potential new treatment for childhood leukemia
Scientists had previously noted that the presence of a large protein called MondoA was associated with worse outcomes in several pediatric cancers, but they didn’t understand why.
Scientists had previously noted that the presence of a large protein called MondoA was associated with worse outcomes in several pediatric cancers, but they didn’t understand why.
Leah Lambert knows cancer care doesn’t always follow a straight line. The registered nurse with a PhD in nursing is focused on improving the patient journey and is working to erase barriers as breast cancer patients transition through their cancer care from diagnosis through to follow-up care with their primary physicians. Working as part of an interdisciplinary team on research and health systems, she has helped outline improvements in care which has led to better patient outcomes and system performance.
Gillian Carleton is no stranger to hard work. The BC Cancer researcher, University of Victoria student and Team Canada Olympic medalist can now include a Vanier Canada Scholarship award under their belt. The award is arguably one of the most prestigious graduate scholarship awards in Canada, offering recipients $50,000 per year for 3 years while they finish their graduate studies.
The new test will be able to better diagnose different types of ovarian cancer, a tool that could one day guide and improve treatment options for patients.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.